linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Company Background  
Divi's Laboratories Ltd.
 
Industry : Pharmaceuticals & Drugs House : Divis Labs
BSE Code 532488
ISIN Demat INE361B01024
Book Value 578.26
NSE Code DIVISLAB
Dividend Yield % 0.46
Market Cap 1747579.66
P/E 69.51
EPS 94.70
Face Value 2  
 
Incorporation Year 12-10 1990  
Registered Office 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli, Hyderabad,
Telangana-500032 .
ISINNO INE361B01024  
Phone 040 66966300 / 400  
E-mail mail@divislabs.com
URL www.divislabs.com
Industry Pharmaceuticals & Drugs  
Chairman Ramesh BV Nimmagadda  
Managing Director Murali K Divi  
Company Secretary M Satish Choudhury  
Listing BSE,NSE  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.